coronavirus vaccine
The Latest
-
Pfizer Pill Becomes First COVID-19 Treatment Approved By FDA
Paxlovid, produced by Pfizer, was shown in clinical trials to reduce the chance of severe sickness by 90%. Paxlovid, produced by Pfizer, was shown in clinical trials to reduce the chance of severe sickness by 90%. -
U.S. FDA Could Authorize COVID-19 Anti-Viral Treatment This Week
Both pills are administered as at-home treatment for those with a higher risk of getting COVID-19. Both pills are administered as at-home treatment for those with a higher risk of getting COVID-19. -
Pfizer's COVID-19 Immunity Protection Drops After Two Months -- Study
A 90% success rate was observed after Pfizer's second dose of prevention against hospitalization and death. A 90% success rate was observed after Pfizer's second dose of prevention against hospitalization and death. -
Pfizer COVID-19 Vaccine Loses Effectiveness Over Time, Scientists Say
The vaccine's efficacy in preventing hospitalization and death remained high for at least six months, researchers say. The vaccine's efficacy in preventing hospitalization and death remained high for at least six months, researchers say. -
Joe Biden Receives His COVID-19 Booster On Camera
The CDC and the FDA backed a booster shot of Pfizer's vaccine last week for individuals 65 years and older. The CDC and the FDA backed a booster shot of Pfizer's vaccine last week for individuals 65 years and older. -
Pfizer CEO Predicts Life 'Back To Normal' Within A year
Pfizer's stock price climbed from $30.99 on March 8, 2020 to $43.94 on Monday. Pfizer's stock price climbed from $30.99 on March 8, 2020 to $43.94 on Monday. -
California Requiring All Health Care Workers To Get Vaccinated
California has become the first U.S. state to require vaccines for all state health care workers. California has become the first U.S. state to require vaccines for all state health care workers. -
Pfizer Says Vaccine's Protection Wanes Over Time
The vaccine was 97% effective at preventing severe illness for at least six months. The vaccine was 97% effective at preventing severe illness for at least six months. -
U.S. FDA Set To Green Light Pfizer COVID-19 Vaccine For 12-15 Year Olds
Johnson & Johnson and Moderna are also testing their vaccines in 12-to-18 year olds. Johnson & Johnson and Moderna are also testing their vaccines in 12-to-18 year olds. -
Pfizer's Fine: COVID-19 Vaccine 91% Effective After Six Months
Vaccine experts say protection from the disease can even last longer. Vaccine experts say protection from the disease can even last longer.